HRMY vs. BMY
Compare and contrast key facts about Harmony Biosciences Holdings, Inc. (HRMY) and Bristol-Myers Squibb Company (BMY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: HRMY or BMY.
Correlation
The correlation between HRMY and BMY is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
HRMY vs. BMY - Performance Comparison
Key characteristics
HRMY:
0.34
BMY:
0.58
HRMY:
0.79
BMY:
1.09
HRMY:
1.10
BMY:
1.14
HRMY:
0.29
BMY:
0.35
HRMY:
1.25
BMY:
1.46
HRMY:
12.31%
BMY:
11.59%
HRMY:
44.86%
BMY:
29.25%
HRMY:
-68.48%
BMY:
-70.62%
HRMY:
-35.82%
BMY:
-26.20%
Fundamentals
HRMY:
$2.23B
BMY:
$110.46B
HRMY:
$2.11
BMY:
-$4.41
HRMY:
$513.47M
BMY:
$48.30B
HRMY:
$399.14M
BMY:
$32.20B
HRMY:
$158.05M
BMY:
$3.16B
Returns By Period
In the year-to-date period, HRMY achieves a 13.60% return, which is significantly higher than BMY's -2.70% return.
HRMY
13.60%
0.10%
9.19%
15.62%
N/A
N/A
BMY
-2.70%
-3.30%
13.61%
14.62%
0.01%
2.13%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
HRMY vs. BMY — Risk-Adjusted Performance Rank
HRMY
BMY
HRMY vs. BMY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Harmony Biosciences Holdings, Inc. (HRMY) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
HRMY vs. BMY - Dividend Comparison
HRMY has not paid dividends to shareholders, while BMY's dividend yield for the trailing twelve months is around 4.45%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HRMY Harmony Biosciences Holdings, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BMY Bristol-Myers Squibb Company | 4.45% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% |
Drawdowns
HRMY vs. BMY - Drawdown Comparison
The maximum HRMY drawdown since its inception was -68.48%, roughly equal to the maximum BMY drawdown of -70.62%. Use the drawdown chart below to compare losses from any high point for HRMY and BMY. For additional features, visit the drawdowns tool.
Volatility
HRMY vs. BMY - Volatility Comparison
Harmony Biosciences Holdings, Inc. (HRMY) and Bristol-Myers Squibb Company (BMY) have volatilities of 8.91% and 8.59%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Financials
HRMY vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Harmony Biosciences Holdings, Inc. and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities